ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of May

May 31, 2013

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

February 23, 1996

NCCS Networker Volume 5 Issue 1, Winter 1991

January 13, 1991

Margaret Kripke Comes Out of Retirement To Become Chief Scientific Officer at CPRIT

December 14, 2012

Guidelines Published On Lung Cancer Treatment

February 28, 2003

Minority Trial Participation A Matter of Access, Study Says

December 30, 2005